|
1
|
Plaks V, Koopman CD and Werb Z: Cancer.
Circulating tumor cells. Science. 341:1186–8. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chaffer CL and Weinberg RA: A perspective
on cancer cell metastasis. Science. 331:1559–1564. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Maheswaran S and Haber DA: Circulating
tumor cells: A window into cancer biology and metastasis. Curr Opin
Genet Dev. 20:96–99. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Baccelli I, Schneeweiss A, Riethdorf S,
Stenzinger A, Schillert A, Vogel V, Klein C, Saini M, Bäuerle T,
Wallwiener M, et al: Identification of a population of blood
circulating tumor cells from breast cancer patients that initiates
metastasis in a xenograft assay. Nat Biotechnol. 31:539–544. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fidler IJ: The pathogenesis of cancer
metastasis: The ‘seed and soil’ hypothesis revisited. Nat Rev
Cancer. 3:453–458. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Giancotti FG: Mechanisms governing
metastatic dormancy and reactivation. Cell. 155:750–764. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ramis-Conde I, Chaplain MA, Anderson AR
and Drasdo D: Multi-scale modelling of cancer cell intravasation:
The role of cadherins in metastasis. Phys Biol. 6:0160082009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gorges TM, Tinhofer I, Drosch M, Röse L,
Zollner TM, Krahn T and von Ahsen O: Circulating tumour cells
escape from EpCAM-based detection due to epithelial-to-mesenchymal
transition. BMC Cancer. 12:1782012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Königsberg R, Obermayr E, Bises G, Pfeiler
G, Gneist M, Wrba F, de Santis M, Zeillinger R, Hudec M and
Dittrich C: Detection of EpCAM positive and negative circulating
tumor cells in metastatic breast cancer patients. Acta Oncol.
50:700–710. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Barrière G, Tartary M and Rigaud M:
Epithelial mesenchymal transition: A new insight into the detection
of circulating tumor cells. ISRN Oncol. 2012:3820102012.PubMed/NCBI
|
|
11
|
Ocaña OH, Córcoles R, Fabra A, et al:
Metastatic colonization requires the repression of the
epithelial-mesenchymal transition inducer Prrx1. Cancer Cell.
22:709–724. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tsai JH, Donaher JL, Murphy DA, Chau S and
Yang J: Spatiotemporal regulation of epithelial-mesenchymal
transition is essential for squamous cell carcinoma metastasis.
Cancer Cell. 22:725–736. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kallergi G, Konstantinidis G,
Markomanolaki H, Papadaki MA, Mavroudis D, Stournaras C,
Georgoulias V and Agelaki S: Apoptotic circulating tumor cells in
early and metastatic breast cancer patients. Mol Cancer Ther.
12:1886–1895. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nakagawa T, Martinez SR, Goto Y, et al:
Detection of circulating tumor cells in early-stage breast cancer
metastasis to axillary lymph nodes. Clin Cancer Res. 13:4105–4110.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nagrath S, Sequist LV, Maheswaran S, Bell
DW, Irimia D, Ulkus L, Smith MR, Kwak EL, Digumarthy S, Muzikansky
A, et al: Isolation of rare circulating tumour cells in cancer
patients by microchip technology. Nature. 450:1235–1239. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu Y and Zhou BP: New insights of
epithelial-mesenchymal transition in cancer metastasis. Acta
Biochim Biophys Sin (Shanghai). 40:643–650. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nguyen DX, Bos PD and Massagué J:
Metastasis: From dissemination to organ-specific colonization. Nat
Rev Cancer. 9:274–284. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yu M, Stott S, Toner M, Maheswaran S and
Haber DA: Circulating tumor cells: Approaches to isolation and
characterization. J Cell Biol. 192:373–382. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Schlüter K, Gassmann P, Enns A, et al:
Organ-specific metastatic tumor cell adhesion and extravasation of
colon carcinoma cells with different metastatic potential. Am J
Pathol. 169:1064–1073. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hou HW, Warkiani ME, Khoo BL, Li ZR, Soo
RA, Tan DS, Lim WT, Han J, Bhagat AA and Lim CT: Isolation and
retrieval of circulating tumor cells using centrifugal forces. Sci
Rep. 3:12592013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yu M, Bardia A, Wittner BS, Stott SL, Smas
ME, Ting DT, Isakoff SJ, Ciciliano JC, Wells MN, Shah AM, et al:
Circulating breast tumor cells exhibit dynamic changes in
epithelial and mesenchymal composition. Science. 339:580–584. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Molnar B, Ladanyi A, Tanko L, Sréter L and
Tulassay Z: Circulating tumor cell clusters in the peripheral blood
of colorectal cancer patients. Clin Cancer Res. 7:4080–4085.
2001.PubMed/NCBI
|
|
23
|
Cianfrocca M and Goldstein LJ: Prognostic
and predictive factors in early-stage breast cancer. Oncologist.
9:606–616. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jonas S, Bechstein WO, Steinmüller T,
Herrmann M, Radke C, Berg T, Settmacher U and Neuhaus P: Vascular
invasion and histopathologic grading determine outcome after liver
transplantation for hepatocellular carcinoma in cirrhosis.
Hepatology. 33:1080–1086. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Falvo L, Catania A, D'Andrea V, Marzullo
A, Giustiniani MC and De Antoni E: Prognostic importance of
histologic vascular invasion in papillary thyroid carcinoma. Ann
Surg. 241:640–646. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nakagohri T, Kinoshita T, Konishi M, Inoue
K and Takahashi S: Survival benefits of portal vein resection for
pancreatic cancer. Am J Surg. 186:149–153. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Adham M, Mirza DF, Chapuis F, Mayer AD,
Bramhall SR, Coldham C, Baulieux J and Buckels J: Results of
vascular resections during pancreatectomy from two European
centres: An analysis of survival and disease-free survival
explicative factors. HPB (Oxford). 8:465–473. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Green TL, Cruse JM, Lewis RE and Craft BS:
Circulating tumor cells (CTCs) from metastatic breast cancer
patients linked to decreased immune function and response to
treatment. Exp Mol Pathol. 95:174–179. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gruber I, Landenberger N, Staebler A, Hahn
M, Wallwiener D and Fehm T: Relationship between circulating tumor
cells and peripheral T-cells in patients with primary breast
cancer. Anticancer Res. 33:2233–2238. 2013.PubMed/NCBI
|
|
30
|
Williams SC: Circulating tumor cells. Proc
Natl Acad Sci USA. 110:48612013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Frisch SM and Screaton RA: Anoikis
mechanisms. Curr Opin Cell Biol. 13:555–562. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liotta LA and Kohn E: Anoikis: Cancer and
the homeless cell. Nature. 430:973–974. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang X, Xu LH and Yu Q: Cell aggregation
induces phosphorylation of PECAM-1 and Pyk2 and promotes tumor cell
anchorage-independent growth. Mol Cancer. 9:72010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kumar S, Park SH, Cieply B, et al: A
pathway for the control of anoikis sensitivity by E-cadherin and
epithelial-to-mesenchymal transition. Mol Cell Biol. 31:4036–4051.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xiao Q, Qu K, Wang C, Kong Y, Liu C, Jiang
D, Saiyin H, Jia F, Ni C, Chen T, et al: HDGF-related protein-3 is
required for anchorage-independent survival and chemoresistance in
hepatocellular carcinomas. Gut. 62:440–451. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tormoen GW, Haley KM, Levine RL and
McCarty OJ: Do circulating tumor cells play a role in coagulation
and thrombosis? Front Oncol. 2:1152012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang Q, Bai X, Chen W, Ma T, Hu Q, Liang
C, Xie S, Chen C, Hu L, Xu S and Liang T: Wnt/β-catenin signaling
enhances hypoxia-induced epithelial-mesenchymal transition in
hepatocellular carcinoma via crosstalk with hif-1α signaling.
Carcinogenesis. 34:962–973. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Misra A, Pandey C, Sze SK and Thanabalu T:
Hypoxia activated EGFR signaling induces epithelial to mesenchymal
transition (EMT). PLoS One. 7:e497662012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Matsuoka J, Yashiro M, Doi Y, Fuyuhiro Y,
Kato Y, Shinto O, Noda S, Kashiwagi S, Aomatsu N, Hirakawa T, et
al: Hypoxia stimulates the EMT of gastric cancer cells through
autocrine TGFβ signaling. PLoS One. 8:e623102013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Salnikov AV, Liu L, Platen M, Gladkich J,
Salnikova O, Ryschich E, Mattern J, Moldenhauer G, Werner J,
Schemmer P, et al: Hypoxia induces EMT in low and highly aggressive
pancreatic tumor cells but only cells with cancer stem cell
characteristics acquire pronounced migratory potential. PLoS One.
7:e463912012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Cannito S, Novo E, Compagnone A, Valfrè di
Bonzo L, Busletta C, Zamara E, Paternostro C, Povero D, Bandino A,
Bozzo F, et al: Redox mechanisms switch on hypoxia-dependent
epithelial-mesenchymal transition in cancer cells. Carcinogenesis.
29:2267–2278. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hong Y and Zhang Q: Phenotype of
circulating tumor cells: Face-off between epithelial and
mesenchymal masks. Tumor Biol. 37:5663–5674. 2016. View Article : Google Scholar
|
|
43
|
Pierga JY, Hajage D, Bachelot T, et al:
High independent prognostic and predictive value of circulating
tumor cells compared with serum tumor markers in a large
prospective trial in first-line chemotherapy for metastatic breast
cancer patients. Ann Oncol. 23:618–624. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Giuliano M, Giordano A, Jackson S, et al:
Circulating tumor cells as prognostic and predictive markers in
metastatic breast cancer patients receiving first-line systemic
treatment. Breast Cancer Res. 13:R672011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
de Bono JS, Scher HI, Montgomery RB,
Parker C, Miller MC, Tissing H, Doyle GV, Terstappen LW, Pienta KJ
and Raghavan D: Circulating tumor cells predict survival benefit
from treatment in metastatic castration-resistant prostate cancer.
Clin Cancer Res. 14:6302–6309. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Schulze K, Gasch C, Staufer K, Nashan B,
Lohse AW, Pantel K, Riethdorf S and Wege H: Presence of
EpCAM-positive circulating tumor cells as biomarker for systemic
disease strongly correlates to survival in patients with
hepatocellular carcinoma. Int J Cancer. 133:2165–2171. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Allard WJ, Matera J, Miller MC, Repollet
M, Connelly MC, Rao C, Tibbe AG, Uhr JW and Terstappen LW: Tumor
cells circulate in the peripheral blood of all major carcinomas but
not in healthy subjects or patients with nonmalignant diseases.
Clin Cancer Res. 10:6897–6904. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Aceto N, Bardia A, Miyamoto DT, Donaldson
MC, Wittner BS, Spencer JA, Yu M, Pely A, Engstrom A, Zhu H, et al:
Circulating tumor cell clusters are oligoclonal precursors of
breast cancer metastasis. Cell. 158:1110–1122. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Visvader JE and Lindeman GJ: Cancer stem
cells in solid tumours: Accumulating evidence and unresolved
questions. Nat Rev Cancer. 8:755–768. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Tinhofer I, Saki M, Niehr F, Keilholz U
and Budach V: Cancer stem cell characteristics of circulating tumor
cells. Int J Radiat Biol. 90:622–627. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Swann JB and Smyth MJ: Immune surveillance
of tumors. J Clin Invest. 117:1137–1146. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Stott SL, Hsu CH, Tsukrov DI, Yu M,
Miyamoto DT, Waltman BA, Rothenberg SM, Shah AM, Smas ME, Korir GK,
et al: Isolation of circulating tumor cells using a
microvortex-generating herringbone-chip. Proc Natl Acad Sci USA.
107:18392–18397. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Hosokawa M, Yoshikawa T, Negishi R,
Yoshino T, Koh Y, Kenmotsu H, Naito T, Takahashi T, Yamamoto N,
Kikuhara Y, et al: Microcavity array system for size-based
enrichment of circulating tumor cells from the blood of patients
with small-cell lung cancer. Anal Chem. 85:5692–5698. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Sollier E, Go DE, Che J, et al:
Size-selective collection of circulating tumor cells using Vortex
technology. Lab Chip. 14:63–77. 2014. View Article : Google Scholar : PubMed/NCBI
|
